That reach is a big part of why it's attracted so much attention in the wellness space
People report theyre just not that interested in food since they started taking drugs like semaglutide, says Stefan Trapp, a neuroscientist at University College London in the UK
Insulin use was reported for 34.6% of patients 180 days before the index date, and 62.1% had used either one or two medications in a GLD class other than GLP-1 RA, most often metformin (50.4%)
Experience the benefits of this innovative weight loss solution, tailored to your specific needs
Together, they create an environment where natural GLP-1 production is maximally supported through multiple independent pathways
[DOI] [PubMed] [Google Scholar] 99.Pinna A., Solinas G., Masia C., Zinellu A., Carru C., Carta A